S. 483: Responsibility in Drug Advertising Act of 2025

S. 483 is a federal bill in the 119th Congress. Currently, pharmaceutical companies can begin running television, print, and social media advertisements directed straight to consumers as soon as the Food and Drug Administration approves a new drug. Under this change, companies will be prohibited from… See its sponsors, how members voted, and a plain-English breakdown on PolityLens.